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Radiologist experience and CT examination
quality determine metastasis detection
in patients with esophageal or gastric
cardia cancer
Abstract We aimed to separate the
influence of radiologist experience
from that of CT quality in the
evaluation of CT examinations of
patients with esophageal or gastric
cardia cancer. Two radiologists from
referral centers (‘expert radiologists’)
and six radiologists from regional
non-referral centers (‘non-expert radi-
ologists’) performed 240 evaluations
of 72 CT examinations of patients
diagnosed with esophageal or gastric
cardia cancer between 1994 and 2003.
We used conditional logistic regres-
sion analysis to calculate odds ratios
(OR) for the likelihood of a correct
diagnosis. Expert radiologists made a
correct diagnosis of the presence or
absence of distant metastases accord-
ing to the gold standard almost three
times more frequently (OR 2.9; 95%
CI 1.4–6.3) than non-expert radiolo-
gists. For the subgroup of CT exam-
inations showing distant metastases, a
statistically significant correlation
(OR 3.5; 95% CI 1.4–9.1) was found
between CT quality as judged by the
radiologists and a correct diagnosis.
Both radiologist experience and qual-
ity of the CT examination play a role
in the detection of distant metastases
in esophageal or gastric cardia cancer
patients. Therefore, we suggest that
staging procedures for esophageal and
gastric cardia cancer should preferably
be performed in centers with techni-
cally advanced equipment and ex-
perienced radiologists.
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Introduction
Staging of patients with esophageal or gastric cardia cancer
is of utmost importance for the selection of an optimal
treatment, which should be aggressive in cases with
potential of cure, but more limited when only palliation
of symptoms is possible. As a result of staging investiga-
tions, the extent of local invasion of the tumor through the
esophageal wall is represented by the T stage, the presence
of regional lymph node metastases by the N stage, and the
presence of distant metastases by the M stage [1].
Esophageal cancer most commonly metastasizes to region-
al, celiac, and supraclavicular lymph nodes; as well as liver,
lung, and adrenal glands [2].
In the Netherlands, upper gastrointestinal (GI) endosco-
pies are mostly performed in regional non-referral centers,
i.e., centers without specific expertise in the treatment of
upper GI cancer. Following a diagnosis of esophageal or
gastric cardia cancer, preoperative staging investigations
are often performed in these regional centers. Thereafter,
patients may be treated in these centers or are referred to a
specialized referral center. In the latter situation, staging
investigations performed in the referring regional center are
usually re-evaluated and/or repeated in the referral center
[3].
In a previous retrospective study, we found that metas-
tases in patients with esophageal or gastric cardia cancer
were more frequently detected on computed tomography
(CT) examinations made and evaluated in a referral center
compared with regional centers. We speculated that this
was caused by the presence of more experienced
radiologists and/or the use of technically more advanced
equipment in the referral center [3]. In the current study, we
aimed to separate radiologist experience from CT quality to
determine the exact role of these factors in the evaluation of
CT examinations of patients with esophageal or gastric
cardia cancer.
Materials and methods
Patients
In the Erasmus MC–University Medical Center Rotterdam,
the Netherlands, a database is maintained with information
on 1,088 patients who have been diagnosed with esoph-
ageal or gastric cardia cancer in the period January 1994 to
October 2003. In 906/1,088 patients, the diagnosis was
made in a regional center and, subsequently, these patients
were referred to our referral center for further evaluation
and/or treatment. In 477/906 patients, no CT examination
was performed in the regional center (n=340) or the CT
performed in the regional center was not re-evaluated and/
or repeated in the referral center (n=137). In the remaining
429 patients, the CT examination performed in the regional
center was re-evaluated and/or repeated. In 235/429
patients, the CT examination was only re-evaluated in
our referral center (re-evaluated CTs), which occurred
when the quality of the CT examination was determined as
sufficient. In 79/429 patients, the quality of the CT
examination performed in the regional center was deter-
mined as insufficient after re-evaluation, and the CT was
therefore subsequently repeated (re-evaluated and repeated
CTs). In 115/429 patients, the CT examination was not re-
evaluated in the referral center, but was immediately
repeated, which became particularly common after 1999
when a new generation of CT systems became available in
the referral center (repeated CTs).
Methods
Two radiologists from two different referral centers for
esophageal and gastric cardia cancer (‘expert radiologists’)
and six radiologists from six different regional centers
(‘non-expert radiologists’) evaluated hard copy CT exam-
inations of patients with esophageal or gastric cardia
cancer. The two referral centers had a volume of more than
100 patients with esophageal or gastric cardia cancer per
year, whereas the total number of patients with esophageal
or gastric cardia cancer in regional centers was low, i.e.,
less than ten cases per year. As a result, radiologists from
the referral centers, with 8 and 13 years of experience
respectively, evaluated more CTs of patients with this
malignancy on a yearly basis than radiologists from the
regional centers, making them ‘expert radiologists’ in the
current study. All radiologists knew that they were part of a
study and considered to be an expert or non-expert
radiologist.
We made a selection of 72 hard copy CT examinations
out of all CTs performed in the 429 patients with a
previously re-evaluated and/or repeated CT. This selection
was stratified according to the following schedule: 26 re-
evaluated CTs from regional centers, 28 repeated CTs (14
from regional centers and 14 from the referral center
performed in the same 14 patients), and 18 re-evaluated
and repeated CTs (nine from regional centers and nine from
the referral center performed in the same nine patients).
This was an almost similar distribution as compared with
the number of re-evaluated and/or repeated CTs in the
period January 1994 to October 2003 in our center. We
decided to include CTs from both regional centers and the
referral center that were performed in the same patient, as
possible differences found could then only be attributed to
the origin of the CTs and not to the characteristics of the
patients. Although the number of patients with distant
metastases in our center is lower than the number of
patients without distant metastases, we decided to choose
for a distribution in which the number of CTs with distant
metastases was more or less equal to those without distant
metastases. CT examinations were randomly selected
taking into account the criteria mentioned above. Of all
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72 CTs evaluated, 37 (51%) had distant metastases,
whereas the other 35 (49%) were without. Celiac lymph
node metastases were considered as regional (N1) if the
primary tumor was located in the gastric cardia and as
distant metastases (M1) if the tumor was located in the
esophagus. The gold standard was the postoperative
pathological TNM stage, the result of fine-needle aspira-
tion (FNA), or a radiological result with ≥6 months of
follow-up. In patients with the gold standard postoperative
pathological TNM stage or the result of FNA, no new
metastases were found in the 6 months following resection
or FNA, which suggests that the results of these gold
standards were reliable. None of the patients received neo-
adjuvant therapy that could have changed the disease
status.
The distribution of CT examinations among the
participating radiologists is shown in Fig. 1. We made
three groups of 24 CT examinations. The two expert
radiologists evaluated 48 CTs, of which one set of 24 CT
examinations was evaluated by both expert radiologists to
determine the variability between these radiologists. The
six non-expert radiologists each evaluated 24 CTs. In order
to determine the variability between non-expert radiolo-
gists, the 24 CTs in each group were evaluated by two non-
expert radiologists. In summary, in group 1 and 3, 24 CTs
were evaluated by one expert and two non-expert
radiologists. In group 2, 24 CTs were evaluated by two
expert and two non-expert radiologists.
Each radiologist evaluated CT examinations from
regional centers and the referral center (Table 1). In
addition, each radiologist randomly evaluated two different
CTs of the same patient, meaning that the CT from the
regional center and that from the referral center were
evaluated by the same radiologist. In group 1, four CTs
from the regional center and four CTs from the referral
center performed in the same patients were evaluated by
the radiologists. In group 2, this number was 6 and in group
3, it was 5. Furthermore, each radiologist evaluated CTs
with metastases as well as CTs without metastases
according to the gold standard (Table 1).
CT examination quality was determined with four
criteria, which were given a score: (a) whether or not
intravenous contrast medium was administered (bolus
enhanced) (yes, 1; no, 2), (b) slice thickness (≤8 mm, 1;
>8 mm, 2), (c) completeness of the CT examination (neck/
thorax/abdomen, 1; missing part, 2), and (d) whether or not
lung window settings were included (yes, 1; no, 2). This
resulted in a score varying between 4 and 8, in which CT
examinations with a score of 4 were considered to be of
72 CT examinations  
expert 1 24 CTs 24 CTs  
expert 2 24 CTs 24 CTs
3 non-experts 24 CTs 24 CTs 24 CTs  
3 non-experts 24 CTs 24 CTs 24 CTs  
(Group 1) (Group 2) (Group 3)
Fig. 1 Distribution of the CT examinations among the various
radiologists
Table 1 Characteristics of CT examinations per group of 24 CTs
Group 1 Group 2 Group 3 Total
n=24 n=24 n=24 n=72
Origin of CT examination
Regional center 16 17 16 49
Referral center 8 7 8 23
Number of patients with CT examination from the regional center and from the referral center 4 6 5 23
N stage
N0 17 11 13 41
N1 7 13 11 31
M stage
M0 12 11 12 35
M1 12 13 12 37
Gold standard
Radiological finding with ≥6 months of follow-up 9 8 5 22
Fine-needle aspiration 6 4 8 18
Postoperative stage 9 12 11 32
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good quality and those with a score of 8 were of poor
quality.
The radiologists evaluated the CTs using a standardized
form on: (a) quality (good/moderate/poor/too poor to
evaluate), (b) presence of tumor (yes/no), and, if ‘yes’, the
primary location (esophagus/gastroesophageal junction/gas-
tric cardia), and (c) presence of metastases (yes/no), and, if
‘yes’, the location. No objective measures for CT quality
were given to the radiologists. All radiologists used normal
daily clinical life criteria which they considered to be
indicated for a CT examination of good, moderate, or poor
quality and, therefore, this grading of quality was subjective.
The study has been carried out with ethical committee
approval.
Statistical analysis
The results of the evaluations of the radiologists were
compared with the gold standard, i.e., the postoperative
pathological TNM stage, the result of fine-needle aspira-
tion (FNA), or a radiological result with ≥6 months of
follow-up. Sensitivities, specificities, and accuracies for N
and M stage were calculated per radiologist. In addition,
sensitivities and specificities were calculated for metastases
per organ, i.e., metastases in regional and celiac lymph
nodes, lung, liver, and adrenal glands. For each group,
results of the radiologists were compared to determine
whether radiologist experience was important in the
evaluation of CT examinations. The McNemar test was
performed to determine whether the differences between
the results of N and M stage were statistically significant.
To determine whether the hospital where the CT had been
performed was important, sensitivities and specificities for
N and M stage were calculated for CTs from regional
centers and from the referral center per radiologist. Further-
more, multivariable conditional logistic regression analysis
was performed to determine the relative importance of
radiologist experience and CT origin, adjusting for the
statistical clustering of multiple CTs of the same patient.
To determine whether CT quality was important,
sensitivities and specificities for N and M stage were
calculated for CTs scored as good or moderate by the
radiologists and for CTs scored as poor or too poor to
evaluate. These results were calculated per radiologist. In
addition, multivariable conditional logistic regression anal-
ysis was repeatedwith CT quality according to the opinion of
each radiologist as an extra covariate in the model.
In addition, conditional logistic regression analysis was
performed for the subgroup of CTs without lymph node or
distant metastases (specificity) and CTs with lymph node or
distant metastases according to the gold standard (sensi-
tivity), to determine whether the role of radiologist
experience and origin and quality of CT examination
were the same for the detection as well as the exclusion of
metastatic disease.
Chi-square testing was used to determine whether a
correlation was present between CT quality according to
the opinion of radiologists on the one hand and the quality
score, radiologist experience, and CT origin on the other
hand.
Software used for the analyses were SPSS (SPSS version
12.0, Chicago, IL) and EGRET (EGRET version 2, Cytel
Software Corporation, Cambridge, MA). All p values were
based on two-sided tests. A p value <0.05 was considered
as statistically significant.
Results
Per radiologist
Radiologist experience
In Table 2, sensitivities, specificities, and accuracies are
shown for each radiologist. The results for N stage differed
per group. For example, in group 1, the highest sensitivity
for N stage was obtained by expert 1 with lower
sensitivities for non-experts 1 and 2, whereas in group 2
the highest sensitivity was obtained by expert 2 and non-
expert 3 with lower sensitivities for expert 1 and non-expert
4. Accuracies for M stage were slightly higher for expert
than for non-expert radiologists. These differences were
however not statistically significant. Five of the eight
radiologists had not evaluated all CT examinations as they
judged the quality of some CTs too poor to allow
evaluation. For that reason, we also calculated sensitivities,
specificities, and accuracies of CT examinations that were
evaluated by all radiologists in each separate group and
these results were compared with the data shown in
Table 2. We found that the results of CTs that were
evaluated by all radiologists of each group (data not
shown) were higher than the results shown in Table 2.
Origin of CT examination
No correlations were found between CT findings and the
hospital where the CT examination had been performed
(Table 3). However, a correlation was found between the
hospital where the CT had been performed and the quality
according to the radiologist. Radiologists gave signifi-
cantly higher quality scores to CT examinations from the
referral center than to those from the regional centers
(Table 4).
Quality of CT examination
In addition to the CT origin, we also looked at the
correlation between quality scores given by the radiologists
and CT findings. Sensitivities for N and M stage were
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higher for CT examinations of good or moderate quality
compared with those of poor quality, whereas specificities
for N and M stage were lower (Table 5).
Nine of 72 CTs (12%) had a quality score of 4 (see
Methods), 20 CTs (28%) of 5, 15 CTs (21%) of 6, 20 CTs
(28%) of 7, and eight CTs (11%) of 8. A correlation was
found between CT quality according to the radiologists and
the calculated quality score (p<0.001). CTs with a score of
4 or 5 were more often judged as of good quality, whereas
CTs with a score of 7 or 8 were often considered too poor
to evaluate. There was no correlation between CT quality
as judged by the radiologists and radiologist experience
(p=0.18).
Conditional logistic regression analyses
Radiologist experience
Conditional logistic regression analysis for N stage showed
no statistically significant correlation between radiologist
experience (expert/non-expert) and a correct diagnosis of
Table 2 Results of evaluated CT examinations per radiologist
Group 1 Group 2 Group 3
Expert 1
(n=24)
Non-expert
1 (n=24)
Non-expert
2 (n=22)
Expert 1
(n=21)
Expert 2
(n=20)
Non-expert
3 (n=22)
Non-expert
4 (n=23)
Expert 2
(n=22)
Non-expert
5 (n=24)
Non-expert
6 (n=24)
Sensitivity (%)
N stage 4/7 (57) 4/7 (57) 1/6 (17) 4/13 (31) 6/11 (55) 9/13 (69) 4/13 (31) 3/9 (33) 4/11 (36) 6/11 (55)
M stage 7/12 (58) 3/12 (25) 1/11 (9) 6/12 (50) 3/10 (30) 9/13 (69) 3/12 (25) 6/10 (60) 4/12 (33) 4/12 (33)
Regional lymph
nodes
4/7 (57) 4/7 (57) 1/6 (17) 4/13 (31) 6/11 (55) 9/13 (69) 4/13 (31) 3/9 (33) 4/11 (36) 6/11 (55)
Celiac lymph
nodes
7/10 (70) 1/10 (10) 0/9 (0) 3/6 (50) 0/4 (0) 2/7 (29) 0/6 (0) 0/5 (0) 0/7 (0) 0/7 (0)
Lung 0/1 (0) 0/1 (0) 0/1 (0) 1/2 (50) 0/2 (0) 1/2 (50) 0/2 (0) – – –
Liver 0/2 (0) 1/2 (50) 1/2 (50) 2/4 (50) 3/4 (75) 2/4 (50) 1/3 (25) 4/5 (80) 4/5 (80) 2/5 (40)
Adrenal gland – – – – – – – – – –
Specificity (%)
N stage 14/17
(82)
9/17 (53) 16/16 (100) 4/8 (50) 8/9 (89) 5/9 (56) 7/10 (70) 10/13
(77)
11/13 (85) 10/13 (77)
M stage 10/12
(83)
9/12 (75) 10/11 (91) 9/9 (100) 10/10
(100)
5/9 (56) 11/11 (100) 12/12
(100)
9/12 (75) 10/12 (83)
Regional lymph
nodes
14/17
(82)
9/17 (53) 16/16 (100) 4/8 (50) 8/9 (89) 5/9 (56) 7/10 (70) 10/13
(77)
11/13 (85) 10/13 (77)
Celiac lymph
nodes
14/14
(100)
14/14 (100) 13/13 (100) 15/15
(100)
16/16
(100)
10/15 (67) 17/17 (100) 17/17
(100)
16/17 (94) 14/17 (82)
Lung 23/23
(100)
22/23 (96) 21/21 (100) 18/19
(95)
18/18
(100)
17/20 (85) 21/21 (100) 22/22
(100)
19/24 (79) 24/24 (100)
Liver 20/22
(91)
19/22 (86) 19/20 (95) 17/17
(100)
16/16
(100)
15/18 (83) 19/19 (100) 15/17
(88)
17/19 (90) 18/19 (95)
Adrenal gland 24/24
(100)
24/24 (100) 22/22 (100) 19/21
(91)
20/20
(100)
21/22 (96) 21/23 (91) 22/22
(100)
24/24 (100) 24/24 (100)
Accuracy (%)
N stage 18/24
(75)
13/24 (54) 17/22 (77) 8/21 (38) 14/20
(70)
14/22 (64) 11/23 (49) 13/22
(59)
15/24 (63) 16/24 (67)
M stage 17/24
(71)
12/24 (50) 11/22 (50) 15/21
(71)
13/20
(65)
14/22 (64) 14/23 (61) 18/22
(82)
13/24 (54) 14/24 (58)
Each group of 24 CTs was evaluated by expert and non-expert radiologists. Five of the eight radiologists had not evaluated all CT examinations
as they judged the quality of some CTs too poor to allow evaluation
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the presence or absence of lymph node metastases
according to the gold standard (odds ratio (OR) 0.9; 95%
confidence interval (CI) 0.5–1.8) (Table 6). A correlation
was also not found for the subgroup of CT examinations
without lymph node metastases (specificity) and CTs with
lymph node metastases (sensitivity), indicating that radi-
ologist experience does not assist in determining N stage.
Conditional logistic regression analysis for M stage
showed that expert radiologists almost three times more
frequently made a correct diagnosis of the presence or
absence of distant metastases than non-expert radiologists
(OR 2.9; 95% CI 1.4–6.3) (Table 6). For the subgroup of
CT examinations without distant metastases this chance
was nearly seven times higher (OR 6.9; 95% CI 1.3–37.0).
The association was less pronounced for the subgroup of
CTs with distant metastases (OR 2.2; 95% CI 0.9–5.5).
These results indicate that radiologist experience is
important in determining M stage, particularly for
confirming the absence of distant metastases.
Origin of CT examination
Conditional logistic regression analysis for N and M stage
showed no statistically significant correlation between CT
origin and a correct diagnosis (Table 6), indicating that the
origin of a CT is not important for detecting metastases in
patients with esophageal or gastric cardia cancer.
Quality of CT examination
Both for N and M stage, conditional logistic regression
analysis showed no correlation between the radiologists’
Table 3 Sensitivity and specificity of CT examinations from the regional center and the referral center
Group 1 Group 2 Group 3
Expert 1
(n=24)
Non-expert
1 (n=24)
Non-expert
2 (n=22)
Expert 1
(n=21)
Expert 2
(n=20)
Non-expert
3 (n=22)
Non-expert
4 (n=23)
Expert 2
(n=22)
Non-expert
5 (n=24)
Non-expert
6 (n=24)
Regional
center
n=16 n=16 n=14 n=14 n=13 n=15 n=16 n=14 n=16 n=16
Sensitivity (%)
N stage 2/4 (50) 2/4 (50) 1/3 (33) 3/9 (33) 4/7 (57) 6/9 (67) 3/9 (33) 2/7 (29) 2/9 (22) 5/9 (56)
M stage 3/7 (43) 2/7 (29) 1/6 (17) 2/8 (25) 1/6 (17) 5/9 (56) 2/8 (25) 4/7 (57) 3/9 (33) 2/9 (22)
Specificity (%)
N stage 11/12
(92)
5/12 (42) 11/11 (100) 2/5 (40) 5/6 (83) 4/6 (67) 5/7 (71) 6/7 (86) 5/7 (71) 5/7 (71)
M stage 8/9 (89) 7/9 (78) 8/8 (100) 6/6 (100) 7/7 (100) 4/6 (67) 8/8 (100) 7/7 (100) 6/7 (86) 7/7 (100)
Referral
center
n=8 n=8 n=8 n=7 n=7 n=7 n=7 n=8 n=8 n=8
Sensitivity (%)
N stage 2/3 (67) 2/3 (67) 0/3 (0) 1/4 (25) 2/4 (50) 3/4 (75) 1/4 (25) 1/2 (50) 2/2 (100) 1/2 (50)
M stage 4/5 (80) 1/5 (20) 0/5 (0) 4/4 (100) 2/4 (50) 4/4 (100) 1/4 (25) 2/3 (67) 1/3 (33) 2/3 (67)
Specificity (%)
N stage 3/5 (60) 4/5 (80) 5/5 (100) 2/3 (67) 3/3 (100) 1/3 (33) 2/3 (67) 4/6 (67) 6/6 (100) 5/6 (83)
M stage 2/3 (67) 2/3 (67) 2/3 (67) 3/3 (100) 3/3 (100) 1/3 (33) 3/3 (100) 5/5 (100) 3/5 (60) 3/5 (60)
Radiologists from the same group evaluated same CTs. Five of the eight radiologists had not evaluated all CT examinations as they judged
the quality of some CTs too poor to allow evaluation
Table 4 Correlation between the CT origin and the quality according to the opinion of the radiologists
Origin Quality
Good Moderate Poor Too poor to evaluate
Referral center 41 (59%) 26 (30%) 8 (13%) 0 (0%)
Regional center 28 (41%) 60 (70%) 52 (87%) 20 (100%)
Linear-by-linear association test: p<0.001
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opinion on CT quality and a correct diagnosis (OR 0.9;
95% CI 0.6–1.6 and OR 1.9; 95% CI 1.0–3.7, respectively)
(Table 6). For the subgroup of CT examinations with
distant metastases, it was however found that the chance to
confirm the presence of distant metastases was 3.5 times
higher for a 1-point-higher quality score compared with a
lower quality score as judged by a radiologist. This
indicates that CT quality is an important factor in
confirming the presence of distant metastases.
Discussion
In this study, two expert and six non-expert radiologists
performed 240 evaluations of 72 hard copy CT examina-
tions of patients diagnosed with esophageal or gastric
cardia cancer to determine whether radiologist experience
and/or CT quality were factors involved in the evaluation
of CT examinations. Our findings showed that expert
radiologists more frequently made a correct diagnosis of
the presence or absence of distant metastases than non-
expert radiologists. For the subgroup of CTs with distant
metastases, a correlation was found between the radiolo-
gists’ opinion on CT quality and a correct diagnosis, which
indicates that, in addition to expertise, CT quality also
plays a role in detecting distant metastases from esophageal
or gastric cardia cancer. However, radiologist experience
and CT quality did not play a role in determining N stage.
Accuracies, sensitivities, and specificities for N and M
stage differed remarkably between radiologists in the
present study. This variation for N stage evaluation in
esophageal cancer has also been reported in the literature,
i.e., from 33 to 86% for accuracy, 22 to 84% for sensitivity,
and 60 to 100% for specificity [4–27]. The same is also true
for M stage, with reported accuracies, sensitivities, and
specificities in the ranges 45–94%, 32–81%, and 11–97%,
respectively [4, 6, 8, 17, 22, 24, 25, 27–30]. The differences
between different radiologists found in our study were
however statistically not significant (Table 2). This could be
due to various reasons. First, the number of evaluated CT
examinations in this study might have been too low to detect
statistically significant differences between radiologists.
Alternatively, it could be that differences between expert
and non-expert radiologists were indeed small, which makes
Table 5 Sensitivity and specificity of CT examinations judged as of good or moderate quality or of poor quality according to the opinion of
each radiologist
Group 1 Group 2 Group 3
Expert 1
(n=24)
Non-expert
1 (n=24)
Non-expert
2 (n=22)
Expert 1
(n=21)
Expert 2
(n=20)
Non-expert
3 (n=22)
Non-expert
4 (n=23)a
Expert 2
(n=22)
Non-expert
5 (n=24)b
Non-expert
6 (n=24)
Quality score: good
or moderate
n=16 n=17 n=16 n=14 n=17 n=9 n=15 n=14 n=14 n=22
Sensitivity (%)
N stage 4/6 (67) 4/5 (80) 0/5 (0) 3/8 (38) 6/9 (67) 4/5 (80) 4/10 (40) 3/6 (50) 2/3 (67) 6/10 (60)
M stage 6/8 (75) 2/10 (20) 0/9 (0) 3/7 (43) 3/9 (33) 5/6 (83) 3/9 (33) 4/7 (57) 4/8 (50) 4/11 (36)
Specificity (%)
N stage 8/10
(80)
6/12 (50) 11/11 (100) 4/6 (67) 7/8 (88) 2/4 (50) 4/5 (80) 7/8 (88) 9/11 (82) 9/12 (75)
M stage 7/8 (88) 5/7 (71) 6/7 (86) 7/7
(100)
8/8
(100)
1/3 (33) 6/6 (100) 7/7
(100)
3/6 (50) 9/11 (82)
Quality score: poor/
too poor to evaluate
n=8 n=7 n=6 n=7 n=3 n=13 n=7 n=8 n=6 n=2
Sensitivity (%)
N stage 0/1 (0) 0/2 (0) 1/1 (100) 1/5 (20) 0/2 (0) 5/8 (63) 0/2 (0) 0/3 (0) 0/4 (0) 0/1 (0)
M stage 1/4 (25) 1/2 (50) 1/2 (50) 3/5 (60) 0/1 (0) 4/7 (57) 0/2 (0) 2/3 (67) 0/4 (0) 0/1 (0)
Specificity (%)
N stage 6/7 (86) 3/5 (60) 5/5 (100) 0/2 (0) 1/1
(100)
3/5 (60) 3/5 (60) 3/5 (60) 2/2 (100) 1/1 (100)
M stage 3/4 (75) 4/5 (80) 4/4 (100) 2/2
(100)
2/2
(100)
4/6 (67) 5/5 (100) 5/5
(100)
2/2 (100) 1/1 (100)
Radiologists from the same group evaluated the same CTs. Five of the eight radiologists had not evaluated all CT examinations as
they judged the quality of some CTs too poor to allow evaluation
aOne CT examination without information on quality
bFour CT examinations without information on quality
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them clinically irrelevant. The first reason seems most likely,
as we found a correlation between radiologist experience and
a correct diagnosis of the presence or absence of distant
metastases in the conditional logistic regression analysis
(Table 6). The confidence intervals for the ORs are wide,
which might also be due to the relatively low number of CTs
that were evaluated.
We think that our finding that expert radiologists were
more likely to make a correct diagnosis with regard to the
presence or absence of distant metastases than non-expert
radiologists is due to differences in radiologist experience.
It may, however, also be due to differences in evaluation
practices between expert and non-expert radiologists. For
example, it may be that expert radiologists are less inclined
to report the presence of distant metastases than non-expert
radiologists. This will lead to fewer false-positive results
(higher specificity), but also to more false-negative results
(lower sensitivity) for expert radiologists. Nevertheless, the
opposite may also be true, i.e., that expert radiologists more
frequently have false-positive results (lower specificity),
but fewer false-negative results (higher sensitivity) than
non-expert radiologists. Nonetheless, this study suggests
that obvious differences in evaluation practices were not
present. For the subgroup of CTs without distant metastases
(specificity), and to a lesser extent for those with distant
metastases (sensitivity), the OR for radiologist experience
was above 1 (Table 6), which indicates that expert
radiologists were more likely to make a correct diagnosis
than non-expert radiologists for both subgroups of CT
examinations.
We also determined whether CT quality was important
for the detection of lymph node and distant metastases. For
Table 6 Conditional logistic regression analyses analyzing whether a correlation is present between radiologist experience, CT quality and
CT origin on the one hand and a correct diagnosis according to the gold standard on the other hand
Variable Odds ratio (95% CI)
Radiologist experience (expert versus non-expert)a
Lymph node metastases
All CT examinations 0.94 (0.50–1.77)
CT examinations with metastases according to gold standard 0.68 (0.25–1.86)
CT examinations without metastases according to gold standard 1.23 (0.52–2.89)
Distant metastases
All CT examinations 2.93 (1.36–6.29)
CT examinations with metastases according to gold standard 2.21 (0.89–5.52)
CT examinations without metastases according to gold standard 6.90 (1.29–37.0)
Origin of CT examination (referral center versus regional center)a
Lymph node metastases
All CT examinations 1.06 (0.46–2.42)
CT examinations with metastases according to gold standard 1.31 (0.37–4.62)
CT examinations without metastases according to gold standard 1.22 (0.52–2.89)
Distant metastases
All CT examinations 0.85 (0.38–1.94)
CT examinations with metastases according to gold standard 0.46 (0.16–1.35)
CT examinations without metastases according to gold standard 2.38 (0.56–10.09)
Quality of CT examinationb
Lymph node metastases
All CT examinations 0.93 (0.56–1.55)
CT examinations with metastases according to gold standard 0.91 (0.41–2.03)
CT examinations without metastases according to gold standard 1.04 (0.53–2.05)
Distant metastases
All CT examinations 1.94 (1.00–3.68)
CT examinations with metastases according to gold standard 3.52 (1.36–9.08)
CT examinations without metastases according to gold standard 0.78 (0.28–2.17)
CI confidence interval
aCovariates are radiologist experience and origin of CT examination
bCovariates are radiologist experience, origin of CT examination, and quality of CT examination (continuous, range 1=good to 4=too poor
to evaluate)
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this, the radiologists were asked to give an opinion on CT
quality. Objective measures for CT quality were not given
to the radiologists and all radiologists used normal daily
clinical life criteria which they considered to be indicated
for a CT examination of good, moderate, or poor quality,
where they took into account, among other factors, use of
contrast medium, slice thickness, and completeness of
the CT examination. Remarkably, the number of CT
examinations of good or moderate quality ranged from 9
to 22 (Table 5), which shows that ranking CT quality is
a subjective matter, in which some radiologists were
more decisive to give lower quality scores than other
radiologists.
The chance to confirm the presence of distant metastases
was higher for higher quality than for lower quality CT
examinations (OR 3.5; 95% CI 1.4–9.1) (Table 6). This
suggests that distant metastases in patients with esophageal
or gastric cardia cancer are not always visible or not easily
detected on CTs of poor quality. A correlation was not
found for the subgroup of CTs without distant metastases
according to the gold standard (OR 0.8; 95% CI 0.3–2.2)
(Table 6), which indicates that CT quality is less important
in confirming the absence of distant metastases. This
finding is clinically important as patients with distant
metastases should preferably undergo a palliative treatment
and not a surgical resection [31].
We also analyzed whether CT origin (regional/referral
center) correlated with a correct diagnosis of the presence
or absence of lymph node or distant metastases. In the
referral center, the newest-generation CT systems were
used during the study period, which was not always true for
the regional centers. In addition, intravenous and oral
contrast medium was always administered in the referral
center, whereas CTs without contrast medium were
performed in some of the regional centers. Particularly,
liver metastases are more readily detected after contrast
enhancement [32, 33]. Our analyses showed no correlation
between CT origin and a correct diagnosis (Table 6).
Nevertheless, a correlation was found between CT origin
and quality according to the opinion of the radiologists,
with higher quality scores for CTs from the referral center
(Table 4).
There are some limitations to this study. First, the study
was not performed in daily clinical practice. The
radiologists who evaluated CT examinations were all
aware of the fact that these CTs had been made in patients
with esophageal or gastric cardia cancer, but had no
information on the results of other staging investigations.
In clinical practice, radiologists are however not always
blinded to these results. Furthermore, 51% of the evaluated
CT examinations were performed in patients with distant
metastases according to the gold standard, whereas the
other CTs were of patients without distant metastases. This
distribution is not like daily clinical practice, with fewer
patients having distant metastases. However, we chose this
distribution, as the number of CT examinations with distant
metastases would otherwise have been too small to draw
conclusions. In addition, CT examinations will often be
reviewed by a multidisciplinary team in daily clinical
practice, which was not the case in our study, in which
radiologists evaluated the CTs alone.
Second, not all radiologists evaluated all available CT
examinations, as they judged the quality of some CTs too
poor to allow a conclusion to be made. We proposed that
CTs that were not evaluated were specifically those for
which it was more difficult to determine whether or not
lymph node or distant metastases were present. To
determine whether this was indeed the case, we also
calculated sensitivities, specificities, and accuracies of CT
examinations that were evaluated by all radiologists in each
separate group. We found that the results of CTs that were
evaluated by all radiologists of each group were higher than
the results shown in Table 2. This suggests that CT
examinations that were not evaluated by radiologists were
indeed CTs for which it was more difficult to determine
whether lymph node or distant metastases were present.
Finally, this study was based on hard copy image data
sets, as the CT examinations used in this study were not
digitally available. Furthermore, some CT examinations
were incomplete, meaning that not the complete thorax
and/or abdomen was present on the examination. Particu-
larly, the lung and liver could not be fully evaluated in
some cases. There are two possible explanations for these
incomplete CTs. First, slides might have been lost over the
years. Second, the ‘missing’ slides were not made due to
the protocol that was used in that center. We assume that
the latter explanation was most likely, as the ‘missing’
slides were always slides above the highest or below the
lowest part of the body that was investigated.
In conclusion, both radiologist experience and quality of
CT examination are important factors in the evaluation of
CT examinations performed in patients with esophageal or
gastric cardia cancer. The results from this study suggest
that staging procedures for esophageal or gastric cardia
cancer should preferably be performed in centers with the
ability to produce high quality CTs and by radiologists with
ample experience in evaluating CT examinations for this
indication, which will optimally allow the detection of
distant metastases from esophageal or gastric cardia cancer.
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